International Oncology Network - Cancer & Hematology News
ESMO 2012: Pazopanib, Another Drug in the Arsenal of Weapons Against Renal Cell Cancer
Cora Sternberg describes an interesting phase III study confirming the positive results for a new drug in RCC treatment. This study was presented during ESMO 2012, the Congress of the European Society for Medical Oncology.
Comment
ADVERTISEMENT
Bookmark / Share
Join the Conversation!
© 2013 Created by Peter Hofland, PhD.
You need to be a member of Onco'Zine to add comments!
Join Onco'Zine